BE606205A - New pharmaceutical compositions comprising 5-nitro-8-hydroxy-quinoline as well as its halogenated derivatives in position 7. - Google Patents

New pharmaceutical compositions comprising 5-nitro-8-hydroxy-quinoline as well as its halogenated derivatives in position 7.

Info

Publication number
BE606205A
BE606205A BE606205A BE606205A BE606205A BE 606205 A BE606205 A BE 606205A BE 606205 A BE606205 A BE 606205A BE 606205 A BE606205 A BE 606205A BE 606205 A BE606205 A BE 606205A
Authority
BE
Belgium
Prior art keywords
quinoline
nitro
hydroxy
well
pharmaceutical compositions
Prior art date
Application number
BE606205A
Other languages
French (fr)
Original Assignee
Docteur Debat Lab De
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Docteur Debat Lab De filed Critical Docteur Debat Lab De
Publication of BE606205A publication Critical patent/BE606205A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/20—Oxygen atoms
    • C07D215/24—Oxygen atoms attached in position 8
    • C07D215/26—Alcohols; Ethers thereof
    • C07D215/28—Alcohols; Ethers thereof with halogen atoms or nitro radicals in positions 5, 6 or 7
BE606205A 1960-07-15 1961-07-17 New pharmaceutical compositions comprising 5-nitro-8-hydroxy-quinoline as well as its halogenated derivatives in position 7. BE606205A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB2473660 1960-07-15

Publications (1)

Publication Number Publication Date
BE606205A true BE606205A (en) 1961-11-16

Family

ID=39319895

Family Applications (1)

Application Number Title Priority Date Filing Date
BE606205A BE606205A (en) 1960-07-15 1961-07-17 New pharmaceutical compositions comprising 5-nitro-8-hydroxy-quinoline as well as its halogenated derivatives in position 7.

Country Status (2)

Country Link
BE (1) BE606205A (en)
FR (1) FR1271M (en)

Also Published As

Publication number Publication date
FR1271M (en) 1962-04-24

Similar Documents

Publication Publication Date Title
FR1320M (en) Pharmaceutical agents based on benzenedisulfonamides.
FR1693M (en) Indole derivatives.
FR2144M (en) Pharmaceutical compositions containing radioactive sources.
FR3195M (en) Pharmaceutical compositions comprising derivatives of theban.
FR1715M (en) Therapeutic composition.
BE606205A (en) New pharmaceutical compositions comprising 5-nitro-8-hydroxy-quinoline as well as its halogenated derivatives in position 7.
FR1443M (en) Dermatological preparation.
FR1045M (en) Anorexigenic compositions.
BE599006A (en) Werner's complex and its preparation.
FR3054M (en) Pharmaceutical preparations.
FR2057M (en) Pharmaceutical compositions based on tetrahydro-isoquinoline derivatives.
FR3376M (en) Pharmaceutical compositions containing quinoline derivatives.
FR1007M (en) Piperazine derivatives for use as medicaments.
BE619267A (en) Depolymerized algin derivatives.
FR383M (en) Anilinobenzoquinone derivatives.
FR1790M (en) Aralkyllaminopyrimidine derivatives and processes for their preparation.
FR1041M (en) New pharmaceutical compositions containing 5-5-diphenyltetrahydrogloxaline-4-one.
FR2954M (en) Aqueous pharmaceutical compositions sterilized in situ.
BE600340A (en) New 1.2-diaryl-3.5-dioxo-pyrazolidines substituted in position 4 and their preparation.
BE600553A (en) New 1.2-diaryl-3.5-dioxo-pyrazolidines substituted in position 4 and their preparation
FR1364M (en) Acridan derivatives.
BE585967A (en) Pharmaceutical compositions containing benzylhydrazine derivatives.
FR1425252A (en) Stable compositions based on vitamins a or its derivatives and stabilizer for this composition
BE575518A (en) Pharmaceutical compositions based on alcopiperidines.
BE604996A (en) 1,2,3,4-tetrahydroquinazolinone derivatives and their preparation